In response to the interim ruling by the Hong Kong High Court on 25 February 2021 regarding Illumina’s patent lawsuit against MGI, MGI makes the following statement: MGI welcomes the court’s decision not to issue an injunction. We respect the court’s judgement and will abide by the undertaking that we made to the court. It should be noted that we have initiated an antitrust lawsuit against Illumina in the United States as a result of its illegal acquisition of patents, and this lawsuit...

In 2019, MGI and YUCEBIO reached a strategic cooperation agreement “Over the last two decades, the field of oncology genomics has witnessed phenomenal growth that wouldn’t have been possible without the joint efforts from the oncology clinical genomic testing service companies. YUCEBIO is one of the leading companies in the field of tumor immunotherapy in China. We started our cooperation in 2018. We have witnessed the rapid development of YUCEBIO in the past two years, and we are glad ...

In response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18 February 2021, MGI makes the following statement: We welcome the Court’s decision to give us the permission to appeal the judgment, and we intend to file its appeal with the Court of Appeal. As permitted by the Court, we will continue to supply sequencing reagents to our existing customers in the UK during the appeal period. Although MGI is appealing aspects of the judgement, it...

A staff member of BIOR, Latvia's Institute of Food Safety, Animal Health and Environment, operates smart automated DNA extraction equipment provided by China's MGI Tech Co., Ltd. in Riga, Latvia (Photo by Janis/Xinhua) RIGA, Feb. 15 (Xinhua) -- Since the outbreak of the coronavirus epidemic in Latvia, Chinese companies have been helping the Baltic country to fight COVID-19 by supplying equipment for automated sample extraction and gene sequencing. When the second COVID-19 wave hit Latvia ...

STOCKHOLM, Feb. 10, 2021 -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughout Sweden greatly improve their COVID-19 testing capabilities from the laboratory at the National Pandemic Center located in Karolinska Institute (KI). Sweden's STV News, the national public television, recently reports that only one percent (1%) of the positive COVID-19 samples have been currently sequenced in Sweden and main regions in the country have been commissioned...

The pandemic has recently been spreading rapidly across the world, posing a formidable challenge to global public health system. As an important measure for the COVID-19 prevention and control, how to improve the capacity of nucleic acid detection has attracted great attention from all countries. As reported on LSM.lv Latvia’s national television, Scientific institute ‘Bior’, which is one of the Covid-19 testing labs in Latvia, will now be able to prepare test samples in larger volumes ...